UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Statistics

Total Valuation

TPE:6794 has a market cap or net worth of TWD 5.08 billion. The enterprise value is 4.42 billion.

Market Cap	5.08B
Enterprise Value	4.42B

Important Dates

The next estimated earnings date is Friday, August 7, 2026.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

TPE:6794 has 63.64 million shares outstanding. The number of shares has increased by 9.32% in one year.

Current Share Class	63.64M
Shares Outstanding	63.64M
Shares Change (YoY)	+9.32%
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	15.17%
Owned by Institutions (%)	n/a
Float	26.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	191.62
PB Ratio	6.03
P/TBV Ratio	6.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-40.31
EV / Sales	166.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.78

Financial Position

The company has a current ratio of 40.56, with a Debt / Equity ratio of 0.07.

Current Ratio	40.56
Quick Ratio	39.00
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.67
Interest Coverage	-96.15

Financial Efficiency

Return on equity (ROE) is -13.51% and return on invested capital (ROIC) is -8.98%.

Return on Equity (ROE)	-13.51%
Return on Assets (ROA)	-8.81%
Return on Invested Capital (ROIC)	-8.98%
Return on Capital Employed (ROCE)	-13.94%
Weighted Average Cost of Capital (WACC)	3.02%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	1.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.04% in the last 52 weeks. The beta is -0.22, so TPE:6794's price volatility has been lower than the market average.

Beta (5Y)	-0.22
52-Week Price Change	+25.04%
50-Day Moving Average	80.93
200-Day Moving Average	80.36
Relative Strength Index (RSI)	47.15
Average Volume (20 Days)	54,877

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6794 had revenue of TWD 26.54 million and -109.59 million in losses. Loss per share was -1.73.

Revenue	26.54M
Gross Profit	16.39M
Operating Income	-125.67M
Pretax Income	-109.59M
Net Income	-109.59M
EBITDA	-113.01M
EBIT	-125.67M
Loss Per Share	-1.73

Balance Sheet

The company has 727.44 million in cash and 60.44 million in debt, with a net cash position of 667.00 million or 10.48 per share.

Cash & Cash Equivalents	727.44M
Total Debt	60.44M
Net Cash	667.00M
Net Cash Per Share	10.48
Equity (Book Value)	843.00M
Book Value Per Share	13.25
Working Capital	746.09M

Cash Flow

In the last 12 months, operating cash flow was -86.58 million and capital expenditures -3.98 million, giving a free cash flow of -90.56 million.

Operating Cash Flow	-86.58M
Capital Expenditures	-3.98M
Depreciation & Amortization	12.66M
Net Borrowing	-6.25M
Free Cash Flow	-90.56M
FCF Per Share	-1.42

Margins

Gross Margin	61.76%
Operating Margin	-473.59%
Pretax Margin	-413.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6794 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.32%
Shareholder Yield	-9.32%
Earnings Yield	-2.16%
FCF Yield	-1.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6794 has an Altman Z-Score of 34.76 and a Piotroski F-Score of 2.

Altman Z-Score	34.76
Piotroski F-Score	2